Cardioprotective Effects of ACE Inhibitors

Mechanisms of Action

ACE inhibitors promote nitric oxide release through prevention of bradykinin breakdown, contributing to beneficial vasodilatory effects beyond simple RAAS blockade, as recommended by the American College of Cardiology 1
ACE inhibitors enhance vasodilation through bradykinin-mediated pathways, leading to improved endothelial function 2
The American Heart Association suggests that ACE inhibitors modify cardiac remodeling more favorably than ARBs in experimental models, reducing remodeling after myocardial infarction 3

The American College of Cardiology recommends ACE inhibitors to reduce morbidity and mortality in heart failure with reduced ejection fraction (HFrEF), providing benefits in patients with mild, moderate, or severe symptoms of heart failure 2
ACE inhibitors improve outcomes in patients with left ventricular dysfunction after myocardial infarction, with a 7% absolute reduction in mortality rate, as shown in the TRACE trial 1
The European Society of Cardiology notes that ACE inhibitors, such as ramipril, can reduce relative mortality risk by 27% in post-MI patients, as demonstrated in the AIRE trial 1

Proper dose titration is crucial to achieve maximal cardioprotective effects, according to the American College of Cardiology 3
Different ACE inhibitors have varying potency but similar clinical effects, emphasizing the importance of individualized treatment plans 3

The American College of Cardiology warns that ACE inhibitors can cause hypotension, especially in volume-depleted patients, and recommends monitoring for hyperkalemia, particularly when combined with other potassium-sparing agents 2
Renal function should be monitored, particularly in patients with pre-existing renal impairment, to minimize the risk of adverse effects 2
Angioedema is a rare but serious side effect, occurring more frequently in blacks and women, and should be closely monitored 2